At the news
? BEARISHIMPACT 5/10 CLUSTER filed Mar 1, 2026 at 19:00 ET
Multiple executives at Ultragenyx Pharmaceutical, including the CFO and Chief Medical Officer, conducted open-market share sales totaling over $317,000 in the past week, while also receiving non-cash stock awards. The selling activity is concentrated among C-suite insiders and represents a modest but notable cluster.
- CFO Howard Horn sold 6,925 shares for $157,236 in open-market transactions.
- Chief Medical Officer Eric Crombez sold 7,029 shares for $160,261 in open-market transactions.
- Dennis Karl Huang (executive) had 999 shares withheld for taxes, valued at $23,367.
- All three insiders also received stock awards totaling 28,923 shares (non-cash, $0 value).
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access